Medical/Pharmaceuticals

Nuctech anti-epidemic sampling isolation cabin and mobile cabin help nucleic acid testing in hospitals of Beijing

BEIJING, July 3, 2020 /PRNewswire/ -- Recently, the temperature in Beijing has been high. Every day, nucleic acid testing medics work outdoors wearing protective clothing and sweating, which is admirable and distressing.

2020-07-03 14:28 2419

New strategic partnership to develop next-generation T cell detection reagents

SHANGHAI, China and COPENHAGEN, Denmark, July 2, 2020 /PRNewswire/ -- Today two MedTech companies, Polaris Biology ofChina and Tetramer Shop of Denmark, announce a strategic partnership to co-develop and distribute technologies that accelerate T cell science. First on the agenda is to commerciali...

2020-07-02 21:00 1312

WellsCare to target Middle Eastern market for its homecare laser pain treatment device

SEOUL, South Korea, July 2, 2020 /PRNewswire/ -- WellsCare, a member company of the Born2Global Centre, will be expanding its presence in theMiddle East starting in July. WellsCare has been an active member company of theBorn2Global Centre since 2019.   WellsCare recently signe...

2020-07-02 20:30 1793

­Antengene Corporation Appoints Former BMS Senior Leader of Biostatistics Zhinuan YU as Corporate Vice President of Biometrics and Regulatory Enabling Functions

SHANGHAI and PHILADELPHIA, July 1, 2020 /PRNewswire/ --Antengene Corporation today announced its appointment of Zhinuan Yu, Ph.D., as Corporate Vice President (CVP) of Biometrics and Regulatory Enabling Functions. Zhinuan will be responsible for providing statistical leadership and strategic r...

2020-07-02 08:16 1557

FibroGenesis Identifies Mechanism Responsible for Blocking COVID19-Like Lung Inflammation

Regenerative Medicine Company Advances Development of Fibroblast-Based Product as an "Off the Shelf"Cell-Treatment for Coronavirus Acute Respiratory Distress Syndrome (ARDS) HOUSTON, July 1, 2020 /PRNewswire/ -- FibroGenesis announced today identification of molecular mechanisms associated with ...

2020-07-02 03:23 1434

Transcenta Announces First Patient Dosed in Phase I Clinical Trial of Claudin18.2 Targeting Monoclonal Antibody TST001 in the US

SUZHOU, China, July 1, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, announced today that the first subject has been dosed successfull...

2020-07-01 23:00 1081

Coronavirus Breakthrough: New Study Highlights Senhwa Biosciences Silmitasertib as Potential Treatment for COVID-19

TAIPEI and SAN DIEGO, July 1, 2020 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on Next Generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, today announced that its drug Silmitasertib was again identified as o...

2020-07-01 21:00 2784

Anti-viral and Anti-Inflammatory Response: GoldenBiotech's Antroquinonol Receives FDA Approval on COVID-19 Phase 2 Trial in USA

TAIPEI, July 1, 2020 /PRNewswire/ -- Golden Biotechnology Corp. (GoldenBiotech, 4132.TWO), a leading Taiwanese biopharmaceutical company, announced that the FDA approved its investigational new drug (IND) application for a Phase II clinical trial of Antroquinonol (Hocena®) on COVID-19 patients in...

2020-07-01 18:36 2940

Immvira Announces the Appointment of Carl Yeung as Chief Financial Officer

SHENZHEN, China, June 30, 2020 /PRNewswire/ -- Today Immvira Group Company (Immvira or the "Company"), a biotechnology company focused on the development of new generation oncolytic viruses as potential cancer therapeutics, announces the appointment ofCarl Yeung as Chief Financial Officer, report...

2020-07-01 08:30 2085

'Curing Cancer without Surgery'

* "Successful disappearance of tumors in subjects upon administering the pain-free anticancer drug, Polytaxel, without side effects such as weight loss." * Suppressed 99.8% of tumors despite a non-toxic dose…more effective than existing FDA-approved pancreatic cancer drugs. * Hopes for a Kore...

2020-06-30 15:10 1508

Alterity Therapeutics meeting with US FDA provides development pathway for ATH434

MELBOURNE, Australia and SAN FRANCISCO, June 29, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") is pleased to announce that it has received guidance from the US Food and Drug Administration (FDA) in relation to the development pathway for ATH434 ...

2020-06-30 11:14 5981

China Biologic Provides Additional Comments on the Xinjiang Deyuan and Shuanglin Transaction

BEIJING, June 29, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today declared that the Company disagrees with the notice delivered by Xinjiang Deyuan Bioeng...

2020-06-29 13:00 11909

PharmAbcine Signs Long-term Contract Manufacturing Organization Agreement for Olinvacimab with Binex

DAEJEON, South Korea, June 26, 2020 /PRNewswire/ -- PharmAbcine (KRX: 208340) (CEO: Jin-san Yoo), biotech company focusing on the development of antibody therapeutics, announced on 18th that it had signed a contract manufacturing organization(CMO) agreement with biologics contract development ...

2020-06-27 00:00 1815

AUD$1.5M NHMRC Awards Grant to Expand Feasibility Trials for Stentrode, the First Interventional Neuromodulation Platform

Synchron's Stentrode brain-computer interface system is a fully-implantable therapeutic being evaluated for its safety and efficacy to restore functional independence via hands-free control of electronic devices in patients with upper limb paralysis SAN FRANCISCO and NEW YORK and MELBOURNE, June...

2020-06-25 10:10 2573

Gencurix wins FDA EUA for COVID-19 Test Kit

SEOUL, South Korea, June 24, 2020 /PRNewswire/ -- A Korean molecular diagnostic company, Gencurix, Inc., has announced that they have received U.S. Food and Drug Administration (FDA)'s Emergency Use Authorization (EUA) for its GenePro SARS-CoV-2 Test.

2020-06-24 21:00 1667

VUNO Obtains CE Mark for 5 of Their Medical AI Solutions

SEOUL, South Korea, June 24, 2020 /PRNewswire/ -- Medical artificial intelligence (AI) solution development companyVUNO Inc. and a member company of theBorn2Global Centre, gained the Class IIa CE markings for five of their AI solutions.

2020-06-24 20:30 1407

United Imaging Reaffirms Commitment to Cybersecurity by Partnering with Clearwater

HOUSTON, June 24, 2020 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, has again affirmed its strategic commitment to leadership in cybersecurity risk management and cybersecurity protection by partnering with Clearwater, the leading provide...

2020-06-24 20:00 1045

Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2020 Financial Results

HONG KONG, June 24, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release financial results fo...

2020-06-24 19:30 14517

Mayne Pharma Announces FDA Filing Acceptance of New Drug Application for E4/DRSP in the US

ADELAIDE, Australia, June 24, 2020 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce the New Drug Application (NDA) for E4/DRSP to prevent pregnancy has been accepted for review by the US Food and Drug Administration (FDA). The FDA is expected to complete its review in ...

2020-06-24 12:10 5796

WAT Medical Delivers 650,000 Digital Thermometers to Canadian Customers

VANCOUVER, BC, June 22, 2020 /PRNewswire/ -- WAT Medical received an order for 650,000 digital thermometers from partners inCanada earlier this year. As of June, WAT Medical has finished manufacturing and delivering all of the requested units in a timely manner, while satisfying all of the specif...

2020-06-22 21:00 1224
1 ... 198199200201202203204 ... 214